Detalhe da pesquisa
1.
Optimizing maintenance therapy in responders to abrocitinib induction: A post hoc analysis of JADE REGIMEN.
J Eur Acad Dermatol Venereol
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38752592
2.
Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo-controlled, randomized, phase III clinical trial (ECZTRA 7).
Br J Dermatol
; 186(3): 440-452, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34698371
3.
Pioneering global best practices in atopic dermatitis: results from the atopic dermatitis quality of care initiative.
Clin Exp Dermatol
; 47(2): 303-311, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382243
4.
Lifetime prevalence and determinants of hand eczema in an adolescent population in Germany: 15-year follow-up of the LISA cohort study.
J Eur Acad Dermatol Venereol
; 36(4): 547-556, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779040
5.
Atopic dermatitis: disease characteristics and comorbidities in smoking and non-smoking patients from the TREATgermany registry.
J Eur Acad Dermatol Venereol
; 36(3): 413-421, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34743344
6.
Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021-a two-round Delphi survey among international experts.
J Eur Acad Dermatol Venereol
; 36(9): 1467-1476, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470457
7.
Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.
Br J Dermatol
; 184(3): 450-463, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33000503
8.
Host traits, lifestyle and environment are associated with human skin bacteria.
Br J Dermatol
; 185(3): 573-584, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33733457
9.
[Quality of care for patients with atopic dermatitis in Germany-no improvements in indicators after ten years]. / Qualität der dermatologischen Versorgung von Neurodermitis in Deutschland keine Verbesserung der Indikatoren nach 10 Jahren.
Hautarzt
; 72(12): 1079-1089, 2021 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-34542647
10.
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema.
Br J Dermatol
; 182(6): 1423-1429, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31444799
11.
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children.
J Eur Acad Dermatol Venereol
; 34(12): 2717-2744, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33205485
12.
Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany.
J Eur Acad Dermatol Venereol
; 34(6): 1263-1272, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31721316
13.
Clinical and molecular response to dupilumab treatment in pediatric atopic dermatitis: Results of the German TREATkids registry.
Allergy
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712730
14.
Atopic dermatitis: the skin barrier and beyond.
Br J Dermatol
; 180(3): 464-474, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29969827
15.
TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries.
Br J Dermatol
; 181(3): 492-504, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719709
16.
TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo- and systemic therapy registries.
Br J Dermatol
; 180(4): 790-801, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29761486
17.
Harmonizing body surface area assessments between the Eczema Area and Severity Index, SCORing Atopic Dermatitis, and handprint methods utilizing one shared measurement-A proposal to improve efficiency and reduce error in atopic dermatitis trials.
J Eur Acad Dermatol Venereol
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385652
18.
[Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany]. / Verminderte berufliche Leistungsfähigkeit und Lebensqualität bei Patienten mit moderater bis schwerer Neurodermitis : Ergebnisse aus dem Deutschen Neurodermitisregister TREATgermany.
Hautarzt
; 69(10): 815-824, 2018 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-30191254
19.
A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal.
Br J Dermatol
; 177(4): 999-1003, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28868633
20.
Basic skin therapy effects on skin inflammation and microbiome composition in patients with atopic dermatitis after challenges with grass pollen.
J Eur Acad Dermatol Venereol
; 36(6): e480-e483, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35075709